Welcome to View from the Top
View from the Top delivers the latest biotechnology industry knowledge through cutting-edge video-driven interviews featuring top biotech executives.
Recent Views
- Gilbert Lam, MicroConstants
- MicroConstants President and CSO Gilbert Lam discusses the CRO's capabilities in pharmacokinetics, bioanalytics, formulation, and metabolism.
- Terrance J. Bruggeman, BioTork
- Terrance J. Bruggeman discusses BioTork's natural solution to the BP oil spill cleanup using variants of naturally occurring organisms.
- Kenneth Aldrich, International Stem Cell Corporation
- Kenneth Aldrich, Chairman of International Stem Cell Corporation, discusses the next generation of therapeutic stem cells.
- Ezra Ernst, Medscape
- Ezra Ernst discusses how to keep physicians current with the latest information and studies via professional development and CME services.
- Vicente Anido, Jr., Ista Pharmaceuticals
- Vicente Anido, Jr. discusses the role of the FDA in the biotech industry, how to achieve profitability.
- Martin Eglitis, Teva Pharmaceutical Industries
- Martin Eglitis discusses Teva’s new Innovative Ventures Program that supports early stage specialty drugs that fill an unmet need.
- Philip Ginsburg, Allied Path
- Philip Ginsburg discusses Allied Path's analysis process for genetic mutation in tumors to tailor treatment to the individual's cancer.
- Nikolay Savchuk, ChemDiv
- ChemDiv CEO Nikolay Savchuk discusses the growing and evolving role of his company and other CROs in the development of therapeutics from target to clinic to manufacturing.
- Theodore R. Schroeder, Cadence Pharmaceuticals
- Theodore R. Schroeder discusses Cadence Pharmaceuticals' intravenous acetaminophen, a new pain management alternative to narcotics.
- Terrance J. Bruggeman, BioTork
- Terrance J. Bruggeman discusses BioTork's natural solution to the BP oil spill cleanup using non-genetically modified microorganisms.
- David Sun, CEO Nanogea
- David Sun discusses how nano-cone chemistry and enabled atomic force technology combine to form the most sensitive molecular diagnostic platform.
- Rick Fultz, BIOCOM Purchasing Group
- Rick Fultz discusses the BIOCOM Purchasing Group, the collective buying power of BIOCOM membership, and securing discount contracts.
- Kim Lim, Ultimate Labs
- Kim Lim discusses Ultimate Lab’s contamination prevention capabilities, outsourcing services within San Diego, how CROs drive profit margin.
- Mark McWilliams, Medipacs
- Mark McWilliams discusses the potential of disposable infusion pumps including safety implications, cost savings.
- Richard Henson, Source Scientific
- Richard Henson on the growing complexity of medical instrumentation, the role of outsourcing product development for the next five years.
- Susan Baxter, Cal State University
- Susan Baxter discusses the C-Superb program aiming to develop a professional workforce for the Life Science industry.
- Kenneth Aldrich, International Stem Cell Corporation
- Kenneth Aldrich, Chairman of International Stem Cell Corporation, discusses the next generation of therapeutic stem cells.
- Mary Fisher, SkinMedica
- Mary Fisher, CEO of SkinMedica, discusses the opportunity in selling to physicians directly, the future of dermatology.
- Daniel M. Bradbury, Amylin Pharmaceuticals
- Daniel M. Bradbury discusses the impact of the FDA approval process on innovation, as well as the potential of stem cell research.
- Mike Ferletic, Enterey Inc.
- Mike Ferletic discusses the benefits of a virtual business model, and offers a case study for building operational efficiency.
- Lawrence B. Cohn, Stradling Yocca Carlson & Rauth
- Lawrence B. Cohn discusses the regulatory pathway for devices from creation to market implementation, and healthcare reform.
- Douglas C. Bryant, Quidel Corporation
- Douglas C. Bryant discusses point of care diagnosis, the corporate impact of the H1N1 virus, and future products for Quidel Corporation.
- Vicente Anido, Jr., President and Chief Executive Officer of Ista Pharmaceuticals
- Vicente Anido, Jr. discusses the role of the FDA in the biotech industry, how to achieve profitability.
- Joe Panetta introduces View from the Top
- Joe Panetta discusses View from the Top including what to expect in the coming months.
Quick Views
Short video clips on a variety of biotech industry topics from top biotech executives.
Featured Sponsor
Top Sponsors
Available Sponsorships
- Video Roll Ins
- Specific Video Page Banner Ads
- Homepage Banner Ads
- Sitewide Banner Ads
